Fig. 12From: Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinomaEstablishment of the nomogram model. A, B Univariate and multivariate Cox analyses of clinical features and risk score. C Nomogram model of overall survival based on Cox regression analysis. D AUC of the risk score, targeted molecular therapy and age. E Calibration curves for predicting overall survival at 1 and 3Â yearsBack to article page